PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $156,560 | -16.2% | 5,103 | +9.4% | 0.00% | – |
Q2 2023 | $186,927 | +10.3% | 4,665 | +12.4% | 0.00% | – |
Q1 2023 | $169,443 | +16.2% | 4,152 | +10.7% | 0.00% | – |
Q4 2022 | $145,764 | -6.6% | 3,751 | +28.0% | 0.00% | -100.0% |
Q3 2022 | $156,000 | -1.9% | 2,930 | +7.4% | 0.00% | 0.0% |
Q2 2022 | $159,000 | -49.2% | 2,727 | -33.6% | 0.00% | 0.0% |
Q1 2022 | $313,000 | +32.6% | 4,107 | +6.6% | 0.00% | 0.0% |
Q4 2021 | $236,000 | – | 3,852 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |